CARDIOVASCULAR: Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results

Audio Journal of Cardiovascular Medicine, November 6th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results AKE HJALMARSON, Sahlgrenska University, Göteborg COMMENT: GORDON TOMASELLI, Johns Hopkins University, Baltmimore REFERENCE: Late Breaking Clinical Trials Session 2 & N Engl J Med 2007;357 The lipid lowering agent rosuvastatin did not bring a significant benefit to older patients with systolic heart failure, according to the findings of the CORONA study released at the American Heart Association sessions in Orlando. Ake Hjalmarson talked with Peter Goodwin about the implications this has for using statins in older patients with heart failure.